ABSTRACT
Objectives The scarcity of epidemiological data on anaemia in low- and middle-income countries, coupled with poor characterisation of overlapping risk factors in high-risk settings and contrasting approaches to the assessment of iron status with inflammation, represent critical gaps to address. This study aimed to characterise the prevalence and profile of iron deficiency anaemia, including adjustment for inflammation, in pregnant and postpartum women, as well as infants from South Africa.
Methods Mother-child dyads (n=394) were recruited (2021-2022) for the Khula birth cohort study in Cape Town, South Africa. Haematological metrics (haemoglobin, mean corpuscular volume [MCV]), iron metrics (serum ferritin and soluble transferrin receptor [sTfR]), and inflammatory biomarkers (highly sensitive C-Reactive Protein [hsCRP]; Alpha-1 Acid Glycoprotein [AGP]) were obtained from mothers antenatally and postnatally, as well as from infants 3-18 months after birth. World Health Organisation (WHO) guidelines were used to classify anaemia and iron deficiency. The extent to which inflammation impacted iron deficiency was assessed using two methods: Method A: higher serum ferritin thresholds for classifying iron status in participants with inflammation (WHO), Method B: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anaemia (BRINDA) regression which corrects serum ferritin levels based on inflammatory biomarker concentrations.
Results Prevalence of anaemia was 34.74% (107/308) in pregnancy and 22.50% (54/240) in mothers at 3-6 months postpartum. Of their infants, 46.82% (125/267) and 48.10% (136/283) were anaemic at least once by 6-12 months and 12-18 months, respectively. When accounting for inflammation using Method A, the prevalence of maternal iron deficiency (regardless of anaemia), increased from 18.35% (20/109) to 55.04% (60/109) in pregnancy, and from 11.97% (28/234) to 46.58% (109/234) postnatally. Similarly, using Method B, the estimated prevalence of maternal iron deficiency increased to 38.53% (42/109) in pregnancy, and 25.21% (59/234) postnatally. In infants at 12-18 months, the prevalence of iron deficiency increased from 19.79% (19/96) to 31.25% (30/96) and 32.29% (31/96) using Methods A and B, respectively. Approximately half of anaemia cases in mothers antenatally (50%; 20/40) and postnatally (45.10%; 23/51), and infants at 12-18 months (55.56%; 10/18), were attributable to iron deficiency. However, there was little overlap in the estimated prevalence of microcytic anaemia (based on MCV) and iron deficiency anaemia (based on adjusted serum ferritin) in pregnant and postpartum mothers, as well as infants at 3-6 and 6-12 months. At these timepoints, microcytic anaemia underestimated the likely proportion of anaemia cases attributable to iron deficiency.
Conclusion This is one of the first studies to report the true prevalence of iron deficiency anaemia in South African mothers and infants, and the extent to which it may be underestimated if inflammation is not accounted for. Additionally, the results indicate that, while microcytic anaemia classification may be a valid proxy for iron deficiency anaemia in infants over 1 year of age, it seems less useful for pregnant and postpartum mothers and younger infants within the context of inflammation. Overall, the findings contribute to a global effort to understand the complex aetiology of iron deficiency anaemia, informing guidelines for optimised detection, prevention, and intervention in high-risk communities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Khula birth cohort was supported by the Wellcome Leap 1kD programme (The First 1000 Days; 222076/Z/20/Z). J.E. Ringshaw is supported by a Wellcome Trust International Training Fellowship (224287/Z/21/Z). The anaemia analyses were funded by the Bill and Melinda Gates Foundation (INV-023509) for K.A. Donald. S.C.R. Williams is supported by the Bill and Melinda Gates Foundation (INV-047888) and the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC). D.J. Stein is supported by the South African Medical research Council (SA-MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee of the University of Cape Town gave ethical approval for this work (reference 666/2021). All mothers provided written informed consent for cohort participation at Khula enrolment, and for their children to participate in study-specific procedures across timepoints. Given the longitudinal nature of the cohort, study consent was obtained from mothers on an annual basis. While specified, approved authors had access to identifiable participant information during data collection, only non-identifiable data was captured and analysed.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
ABBREVIATIONS
- AEQ
- Alcohol Exposure Questionnaire
- AGP
- Alpha-1Acid Glycoprotein
- ASSIST
- Alcohol, Smoking, and Substance Involvement Screening Test
- BRINDA
- Biomarkers Reflecting Inflammation and Nutritional Determinants of Anaemia
- CDC
- Centers for Disease Control
- COPE-IS
- Coronavirus Perinatal Experiences – Impact Survey
- COVID-19
- Coronavirus Disease 2019
- EPDS
- Edinburgh Postnatal Depression Scale
- FBC
- Full Blood Count
- HAZ
- Height-for-Age
- Hb
- Haemoglobin
- HCZ
- Head-Circumference-for-Age
- HIV
- Human Immunodeficiency Virus
- hsCRP
- Highly Sensitive C-Reactive Protein
- IDA
- Iron Deficiency Anaemia
- LMIC
- Low- and Middle-Income Country
- MCV
- Mean Corpuscular Volume
- NHLS
- National Health Laboratory Services
- PHDC
- Provincial Health Data Centre
- ReMAPP
- Redefining Maternal Anemia in Pregnancy and Postpartum
- REVAMP
- Randomised controlled trial of the Effect of Intra-Venous Iron on Anaemia in Malawian Pregnant women
- SDG
- Sustainable Development Goal
- SPSS
- Statistical Package for the Social Sciences
- sTfR
- Soluble Transferrin Receptor
- TSAT
- Transferrin Saturation
- UN
- United Nations
- UNICEF
- United Nations International Emergency Fund
- WAZ
- Weight-for-Age
- WHO
- World Health Organization
- ZAR
- South African Rands
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.